| 1 |
胡莉娟，刘若雨，周允，等. 基于检验指标构建多参数模型在特发性肺纤维化临床评估中的应用[J]. 中华检验医学杂志，2024, 47(10): 1139-1151.
|
| 2 |
吴逢波，孙闻续，蒋艾豆，等. 吡非尼酮治疗特发性肺纤维化的快速卫生技术评估[J]. 医药导报，2021, 40(4): 515-519.
|
| 3 |
许银姬，金蕊，苗姝. 吡非尼酮联合醋酸泼尼松治疗特发性肺纤维化的临床疗效[J]. 保健医学研究与实践，2022, 19(2): 6-8, 27.
|
| 4 |
杨怡恬，叶威龙，姚卫民. 纤维化间质性肺疾病中咳嗽的流行病学及预后意义[J]. 中华结核和呼吸杂志，2024, 47(10): 990-995.
|
| 5 |
徐义峰，柯诗文，肖航，等. 特发性肺纤维化中基底膜相关标志物探索及治疗药物预测[J]. 医药导报，2024, 43(8): 1338-1346.
|
| 6 |
邱凌霄，王创业，卿斌，等. 基于转录组学筛选特发性肺纤维化的枢纽基因和信号通路[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(2): 212-217.
|
| 7 |
León-Román F, Valenzuela C, Molina-Molina M. Idiopathic pulmonary fibrosis[J]. Med Clin (Barc), 2022, 159(4): 189-194.
|
| 8 |
秦喜竹，李慧雅，陈海丽. 有氧抗阻肺康复疗法对激素治疗特发性肺纤维化患者临床疗效及相关炎症介质表达的影响[J]. 临床和实验医学杂志，2023, 22(5): 477-481.
|
| 9 |
姜福富，覃纲，李嘉燕，等. 特发性肺纤维化急性加重期患者NLRP3炎症小体、炎症因子、蛋白酶表达水平及其临床价值[J]. 中国老年学杂志，2022, 42(20): 4974-4977.
|
| 10 |
Wang L, Zhu M, Li Y, et al. Serum proteomics identifies biomarkers associated with the pathogenesis of idiopathic pulmonary fibrosis[J]. Mol Cell Proteomics, 2023, 22(4): 100524.
|
| 11 |
Zhang T, Liu Q, Gao W, et al. The multifaceted regulation of mitophagy by endogenous metabolites[J]. Autophagy, 2022, 18(6): 1216-1239.
|
| 12 |
Samuvel DJ, Li L, Krishnasamy Y, et al. Mitochondrial depolarization after acute ethanol treatment drives mitophagy in living mice[J]. Autophagy, 2022, 18(11): 2671-2685.
|
| 13 |
贺宏健，韦兰成，石倩倩，等. 锰诱导BV2细胞炎症活化与线粒体自噬有关[J]. 广西医科大学学报，2024, 41(7): 989-995.
|
| 14 |
Hui S, George J, Kapadia M, et al. Mitophagy upregulation occurs early in the neurodegenerative process mediated by α-synuclein[J]. Mol Neurobiol, 2024, 61(11): 9032-9042.
|
| 15 |
吴沛玲，娄月妍，张洪艳，等. 线粒体相关基因在特发性肺纤维化中的分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(2): 178-184.
|
| 16 |
汤友静，牛玉娜，王辉. Pink1/Parkin介导的线粒体自噬分子机制[J]. 中国细胞生物学学报，2017, 39(7): 939-946.
|
| 17 |
Sun Y, Cao Y, Wan H, et al. A mitophagy sensor PPTC7 controls BNIP3 and NIX degradation to regulate mitochondrial mass[J]. Mol Cell, 2024, 84(2): 327-344.
|
| 18 |
Li Y, Chen H, Xie X, et al. PINK1-mediated mitophagy promotes oxidative phosphorylation and redox homeostasis to induce drug-tolerant persister cancer cells[J]. Cancer Res, 2023, 83(3): 398-413.
|
| 19 |
Zhao G, Zhang T, Li J, et al. Parkin-mediated mitophagy is a potential treatment for oxaliplatin-induced peripheral neuropathy[J]. Am J Physiol Cell Physiol, 2024, 326(1): C214-C228.
|
| 20 |
Gao A, Wang M, Tang X, et al. NDP52 SUMOylation contributes to low-dose X-rays-induced cardiac hypertrophy through PINK1/Parkin-mediated mitophagy via MUL1/SUMO2 signalling[J]. J Cell Physiol, 2024, 239(1): 79-96.
|
| 21 |
Choi GE, Lee HJ, Chae CW, et al. BNIP3L/NIX-mediated mitophagy protects against glucocorticoid-induced synapse defects[J]. Nat Commun, 2021, 12(1): 487.
|
| 22 |
Liu L, Li Y, Wang J, et al. Mitophagy receptor FUNDC1 is regulated by PGC-1α/NRF1 to fine tune mitochondrial homeostasis[J]. EMBO Rep, 2021, 22(3): e50629.
|
| 23 |
Cameli P, Carleo A, Bergantini L, et al. Oxidant/Antioxidant Disequilibrium in Idiopathic Pulmonary Fibrosis Pathogenesis[J]. Inflammation, 2020, 43(1): 1-7.
|
| 24 |
Pan L, Cheng Y, Yang W, et al. Nintedanib ameliorates bleomycin-induced pulmonary fibrosis, inflammation, apoptosis, and oxidative stress by modulating PI3K/Akt/mTOR pathway in mice[J]. Inflammation, 2023, 46(4): 1531-1542.
|
| 25 |
Meng Y, Pan M, Zheng B, et al. Autophagy attenuates angiotensin Ⅱ-induced pulmonary fibrosis by inhibiting redox imbalance-mediated nod-like receptor family pyrin domain containing 3 inflammasome activation[J]. Antioxid Redox Signal, 2019, 30(4): 520-541.
|
| 26 |
Rimessi A, Pozzato C, Carparelli L, et al. Pharmacological modulation of mitochondrial calcium uniporter controls lung inflammation in cystic fibrosis[J]. Sci Adv, 2020, 6(19): eaax9093.
|
| 27 |
Tian Z, Yao N, Wang F, Ruan L. Thymosin β4 suppresses LPS-induced murine lung fibrosis by attenuating oxidative injury and alleviating inflammation[J]. Inflammation, 2022, 45(1): 59-73.
|
| 28 |
杜欣倩，崔烨. 肺泡上皮细胞和巨噬细胞在特发性肺纤维化中的相互作用[J]. 微生物学免疫学进展，2023, 51(5): 61-67.
|
| 29 |
Chung KP, Cheng CN, Chen YJ, et al. Alveolar epithelial cells mitigate neutrophilic inflammation in lung injury through regulating mitochondrial fatty acid oxidation[J]. Nat Commun, 2024, 15(1): 7241.
|
| 30 |
Patel AS, Song JW, Chu SG, et al. Epithelial cell mitochondrial dysfunction and PINK1 are induced by transforming growth factor-beta1 in pulmonary fibrosis[J]. PLoS One, 2015, 10(3): e0121246.
|
| 31 |
Bueno M, Lai YC, Romero Y, et al. PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis[J]. J Clin Invest, 2015, 125(2): 521-38.
|
| 32 |
Guan R, Yuan L, Li J, et al. Bone morphogenetic protein 4 inhibits pulmonary fibrosis by modulating cellular senescence and mitophagy in lung fibroblasts[J]. Eur Respir J, 2022, 60(6): 2102307.
|
| 33 |
Wang W, Zhang Y, Huang W, et al. Alamandine/MrgD axis prevents TGF-β1-mediated fibroblast activation via regulation of aerobic glycolysis and mitophagy[J]. J Transl Med, 2023, 21(1): 24.
|
| 34 |
Sosulski ML, Gongora R, Danchuk S, et al. Deregulation of selective autophagy during aging and pulmonary fibrosis: the role of TGFβ1[J]. Aging Cell, 2015, 14(5): 774-83.
|
| 35 |
Santarelli R, Arteni AMB, Gilardini Montani MS, et al. KSHV dysregulates bulk macroautophagy, mitophagy and UPR to promote endothelial to mesenchymal transition and CCL2 release, key events in viral-driven sarcomagenesis[J]. Int J Cancer, 2020, 147(12): 3500-3510.
|
| 36 |
Xu M, Wang X, Xu L, et al. Chronic lung inflammation and pulmonary fibrosis after multiple intranasal instillation of PM2.5in mice[J]. Environ Toxicol, 2021, 36(7): 1434-1446.
|
| 37 |
Zhong WJ, Zhang J, Duan JX, et al. TREM-1 triggers necroptosis of macrophages through mTOR-dependent mitochondrial fission during acute lung injury[J]. J Transl Med, 2023, 21(1): 179.
|
| 38 |
Zhu L, Fu X, Chen X, et al. M2 macrophages induce EMT through the TGF-β/Smad2 signaling pathway[J]. Cell Biol Int, 2017, 41(9): 960-968.
|
| 39 |
Larson-Casey JL, Deshane JS, Ryan AJ, et al. Macrophage Akt1 kinase-mediated mitophagy modulates apoptosis resistance and pulmonary fibrosis[J]. Immunity, 2016, 44(3): 582-596.
|
| 40 |
Vancheri C, Kreuter M, Richeldi L, et al. Nintedanib with add-on pirfenidone in idiopathic pulmonary fibrosis. Results of the INJOURNEY trial[J]. Am J Respir Crit Care Med, 2018, 197(3): 356-363.
|
| 41 |
Kurita Y, Araya J, Minagawa S, et al. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy[J]. Respir Res, 2017, 18(1): 114.
|
| 42 |
Yu G, Tzouvelekis A, Wang R, et al. Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function[J]. Nat Med, 2018, 24(1): 39-49.
|
| 43 |
孙春斌，应艺，侯迥，等. 三七总皂苷抑制PI3 K/AKT/mTOR信号通路激活自噬缓解小鼠肺纤维化的实验研究[J]. 时珍国医国药，2020, 31(12): 2872-2876.
|
| 44 |
张兴，张炜，蔡淦. 扶正通络方调控自噬对肺纤维化的影响[J]. 中华中医药杂志，2020, 35(11): 5455-5459.
|